ArticleJournal of hepatocellular carcinoma2026
Nomogram Based on Tumor Burden Score and Inflammation-Nutritional Indicators to Predict the Prognosis of Hepatocellular Carcinoma Patients Undergoing TACE Combined with Targeted and Immunotherapy.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Post-Treatment Prognostic Nutritional Index Outperforms Baseline Index as an Independent Prognostic Biomarker in Advanced Hepatocellular Carcinoma Receiving Immune-Based Systemic Therapy.Journal of hepatocellular carcinoma · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to develop and validate a prognostic model integrating the tumor burden score (TBS) with inflammation-nutritional indicators for patients with intermediate-to-advanced hepatocellular carcinoma (HCC). The model was designed to predict outcomes in patients undergoing triple therapy with transarterial chemoembolization (TACE), targeted therapy, and immunotherapy. Its predictive performance was subsequently assessed. Patients and Methods: The training cohort comprised 112 eligible patients treated at Ganzhou People's Hospital between September 2021 and June 2024, while an external validation cohort included 84 patients from the First Affiliated Hospital of Gannan Medical University. Cox regression analysis identified independent prognostic factors for overall survival (OS), and a nomogram was constructed from these predictors. We assessed the model's performance using the concordance index (C-index), time-dependent receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Based on the nomogram-derived risk scores, patients were stratified into low- and high-risk groups. Differences in OS between these groups were compared with Kaplan-Meier curves and the Log rank test. Results: Multivariate Cox analysis identified TBS, the prognostic nutritional index (PNI), the systemic immune-inflammation index (SII), and extrahepatic metastasis as independent predictors of OS (P < 0.05). The nomogram achieved a C-index of 0.778 (95% CI: 0.719-0.838) in the training cohort and 0.689 (95% CI: 0.606-0.772) in the external validation cohort. After bootstrap correction, the C-index was 0.793 (95% CI: 0.738-0.848). This model consistently outperformed conventional clinical staging systems in both C-index and AUC values, while calibration curves and decision curve analysis affirmed its predictive accuracy and clinical utility. Kaplan-Meier analysis confirmed a significant difference in overall survival between the low- and high-risk groups. Conclusion: The nomogram incorporating TBS and inflammation-nutritional indicators exhibits acceptable prognostic performance and effectively identifies high-risk patients, providing valuable guidance for clinicians in risk stratification and individualized treatment planning.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.